KeyCorp Issues Pessimistic Forecast for Alignment Healthcare (NASDAQ:ALHC) Stock Price

Posted by Francis Steltz on Oct 9th, 2026

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) had its price target cut by research analysts at KeyCorp from $28.00 to $12.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s target price would suggest a potential upside of 37.77% from the company’s current price.

A number of other equities analysts have also recently issued reports on ALHC. Wall Street Zen cut Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Raymond James Financial lowered Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and reduced their target price for the stock from $22.00 to $19.00 in a research note on Monday, August 3rd. JPMorgan Chase & Co. decreased their target price on Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating for the company in a research report on Tuesday, August 4th. Weiss Ratings raised shares of Alignment Healthcare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, September 25th. Finally, TD Cowen restated a “buy” rating on shares of Alignment Healthcare in a report on Wednesday, September 16th. Seven research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $21.40.

Read Our Latest Report on ALHC

Alignment Healthcare Stock Up 1.9%

Shares of NASDAQ ALHC opened at $8.71 on Friday. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. The company has a market cap of $1.81 billion, a P/E ratio of 45.84 and a beta of 1.14. Alignment Healthcare has a 1 year low of $7.37 and a 1 year high of $25.12. The firm has a 50-day simple moving average of $11.64 and a two-hundred day simple moving average of $16.70.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.04. The business had revenue of $1.34 billion during the quarter, compared to analyst estimates of $1.31 billion. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The company’s revenue for the quarter was up 31.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.07 earnings per share. Research analysts anticipate that Alignment Healthcare will post 0.17 earnings per share for the current year.

Insider Transactions at Alignment Healthcare

In other Alignment Healthcare news, EVP Joseph S. Konowiecki sold 23,511 shares of Alignment Healthcare stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $8.61, for a total transaction of $202,429.71. Following the completion of the sale, the executive vice president directly owned 1,080,305 shares of the company’s stock, valued at $9,301,426.05. The trade was a 2.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, President Dawn Maroney sold 122,707 shares of Alignment Healthcare stock in a transaction on Friday, September 11th. The shares were sold at an average price of $12.68, for a total value of $1,555,924.76. Following the sale, the president directly owned 794,606 shares of the company’s stock, valued at approximately $10,075,604.08. This trade represents a 13.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 1,061,967 shares of company stock worth $13,642,490 over the last three months. Company insiders own 5.20% of the company’s stock.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the company. Wellington Management Group LLP increased its stake in shares of Alignment Healthcare by 9.8% during the second quarter. Wellington Management Group LLP now owns 18,780,363 shares of the company’s stock valued at $447,160,000 after buying an additional 1,681,427 shares during the period. William Blair Investment Management LLC purchased a new stake in Alignment Healthcare in the second quarter worth about $184,799,000. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Alignment Healthcare in the second quarter worth about $87,794,000. Bank of New York Mellon Corp purchased a new stake in Alignment Healthcare in the second quarter worth about $87,077,000. Finally, Bank of America Corp DE grew its holdings in Alignment Healthcare by 156.5% during the 1st quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock worth $56,660,000 after acquiring an additional 1,961,778 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc is a technology-enabled Medicare Advantage company focused on providing health coverage and care services for older adults. The company offers Medicare Advantage plans that combine medical benefits with care coordination, wellness support, and other services designed to help members manage their health.

Alignment operates through an integrated healthcare model that uses its proprietary technology platform to support physicians, care teams, and members. Its services include personalized care management, clinical coordination, virtual and in-home support, and member assistance through its concierge-style approach.